BEXIMCO Bus 101

An In-Depth Analysis Of
Beximco Pharmaceuticals
Course- BUS101 Section- 14
Submitted To : Noor-E-Hasnim
Lecturer, School Of Business
NorthSouth University
Prepared By:
Md.Salehin Shahriar…………………… ID- 1220711030

Tanisha Khan…………………………… ID- 1411229030
Rohit Kumar Agarwala………………… ID- 1330857630
MD. Sakib Asad Khan………………….. ID- 1510261630
Sahida Akter Liya………………………. ID- 1512721030
Kawsar Jahan Binti……………………... ID- 1511787030
INTRODUCTION
 Beximco Pharmaceuticals Ltd. ( Beximco Pharma) is a part of

Beximco Group.
 The largest private sector industrial conglomerate in Bangladesh.
 Leading manufacturer of pharmaceuticals - both finished
formulations and Active Pharmaceutical Ingredients ( APIs).
 Number 1 exporter of pharmaceuticals in the country having a
global footprint in 45 countries.
 Has more than 2,500 employees; runs its own distribution channel
nationwide, and its products are trusted by physicians and patients
at home and abroad.
 Ranks second among more than 200 pharmaceutical companies in
the domestic market
COMPANY BACKGROUND
 Beximco was founded in the 1970’s by two brothers – Ahmed Sohail

Fasiur Rahman and Ahmed Salman Fazlur Rahman.
 Since the early days, the Group has evolved from being primarily a
commodities trading company to a leading, diversified group with a
presence in industry sectors that account for nearly 75% of
Bangladesh’s GDP. Beximco’s corporate mission is “Taking
Bangladesh to the world”.
 As Beximco has grown over the years, the flagship platform now
has operations and investments across a wide range of industries
including textiles, trading, marine food, real estate development,
hospitality, construction, information and communication
technologies, media, ceramics, aviation, pharmaceuticals, financial
services and energy.
 Beximco is the largest employer in the private sector in Bangladesh
and employs over 48,000 people worldwide.
MISSION & VISION
Mission : We are committed to
enhancing human health and well-
being by providing contemporary
and affordable medicines,
manufactured in full compliance with
global quality standards. We
continually strive to improve our core
capabilities to address the unmet
medical needs of the patients and to
deliver outstanding results for our
shareholders.
Vision : We will be one of the most

trusted, admired and successful
pharmaceutical companies in the
region with a focus on strengthening
research and development
capabilities, creating partnerships
and building presence across the
globe.
ORGANIZATIONAL CHART
The Articles & Bylaws Of Beximco
Pharmaceuticals Ltd.
 Operational Headquarters -19 Dhanmondi R/A,Road No.-7,Dhaka
1205, Bangladesh.
 Applications of Assets- The assets and income of the Beximco
Pharmaceuticals shall be used for payment to the Members of the
Executive Committee or members of Beximco Pharmaceuticals or
shareholders by way of profit, dividend, interest, loan etc.
 Executive Committee-The Executive Committee meets on a
quarterly basis and its range of applications includes business
review, budget approval, and senior management
appraisal.Executive committee consists of five members :
Mr. O.K. Chowdhury
Nazmul Hassan
Rabbur Reza
Ali Nawaz
Afsar Uddin Ahmed
Pharmaceuticals Ltd(Cont.)
 Right to General Shareholders:The rights of the shareholders
(including the holders of AIM Securities) of the Company are
included in the Bangladesh Companies Act 1994, the Bangladesh
Securities and Exchange Ordinance 1969 (together with the
Bangladesh Securities and Exchange Commission Act 1993 and the
rules made thereunder) and the rules of the Dhaka Stock Exchange
(DSE) and the Chittagong Stock Exchange (CSE); and the
Company's Articles of Association.
 Shareholders'Meetings -
At any general meeting:

1)On a show of hands, every member who is present in person shall
have one vote.
2)On a poll, every member who is present in person or by proxy has
one vote for every share of which he is the holder.
Pharmaceuticals Ltd(Cont.)
Removal of Directors: The shareholders of
a company may, by extraordinary
resolution in a general meeting, remove
any director and appoint a director to fill
that vacancy.
Constitution :The memorandum and
articles of association are the constitutional
documents of a Bangladeshi company.
Beximco pharma’s memorandum and
articles of association (other than the
objects clause) may be altered by a
special resolution of the shareholders in
general meeting.
Advantages & Disadvantages Of BPL As A
Corporation
ADVANTAGES :
 Limited liability protection provided to its owners.
 Ablility to raise additional funds by selling its shares.
 Attract key and talented employees.
 Shareholders do not typically participate in the operations of
Beximco,
 The board sets corporates policy and strategy for the corporation.
 Beximco will continue to exist until the shareholders decide to
dissolve it or merge with another business.
 Freely transferable shares.
Advantages & Disadvantages Of BPL As A
Corporation (Cont.)
Disadvantages :
 Corporate formalities.
 Excessive paperwork. Reports
and tax returns must be
compiled and filed in a timely
fashion; business bank
accounts and records must be
kept of corporate actions,
including meetings of
shareholders and Board of
Directors.
 DoubleTaxation.
 Storage problem of certain
medicines.
Products Offered By Beximco
Pharmaceuticals Limited(BPL).
 Allergic Disordors: Bexidal, Odeson, Atrizin, Axodin, Curin,
Momento, Pedamin, Pretin, BeXIPRED, ODESON.
 Analgesics and Antipynetic: Lucidol Injection, Napa, Napa Extend,
Napa Dol, Napa.
 Anti-infective: Arixon, Arlin, Azithrocin IV, Clinacyn clobex, Etrocin,
Evo, Filmet.
 Cardiovascular: Amdova, Cleven 60, Notrosol, Amdocal-10,
Amdocal Plus-50, Atova-20, Bizoran 5/40.
 Central Nervous System: olemesan plus, pacet, Primace@5,
Porosan 50, Prosan HZ, Resitone.
Products Offered By Beximco
Pharmaceuticals Limited(Cont.)
 Eye Care: Xalanol Eye Drops.
 Gastrointestinal: Aeifix, Pantolex 40.
 Intravenous Fluids: Dexaaqva, Nutrimin.
 Muscloseletal: Voligel
 Oncology: ONSAT OSF
 Respiratony: Mucomist DT, BexitroL-F, Symbion Bexicap 200,
Tioriva Bexicap.
 Skin Care: Q-RASH
 Vitamins and Minerals supplement: Calorate KIT, Calorate, Jointce
Max, Bextram Gold, Aristovit-B.
Specialized Products Of Beximco
Pharmaceuticlas
Arlin & Napa Decomit 50 HFA
Opton 40 & Proceptin 40 Xalamprost

Specialized Products Of Beximco
Pharmaceuticlas (Contd.)
Deconpril Onsat 8
Cesonide HFA 80 Syringe

INDUSTRY ANALYSIS
1) Major Competitors :
A) Local Competitor :Most prominent local competitors of Beximco
Pharmaceuticals are-
 Square Pharmaceuticals Ltd. (leading the market share )
 Incepta
 Opsonin
 Escayef
 Acme
 ACI
 Renata
 Aristopharma
 DrugInternational
INDUSTRY ANALYSIS (Cont.)
INDUSTRY ANALYSIS (Cont.)
B) International Competitors :
 Due to very low barriers to entry, Indian pharmaceutical industry is
highly fragmented with about 250 large manufacturing units and
about 18,000 small units spread across our country. This makes
Bangladesh pharmaceutical market increasingly competitive.
 The industry witnesses price competition, which reduces the growth
of the industry in value term. To put things in perspective, in the
year 2004 the industry actually grew by 8.6%.
 Also, people now-a-days can purchase any brand of medicine
through online from anywhere around the globe.
SWOT Analysis Of Beximco
Pharmaceuticals Limited
Strengths
• Diversification
• Achievement of National Export Trophy
• Research & Development(R&D)
• Strong Brand Name
• Highest Market Share In Exporting
• Metered Dose Inhaler Plant(MDI Plant)
• Corporate Social Responsibilities (CSR)
Weaknesses
• Lack Of Product Patent
• Customer Dissatisfaction Due to Higher Price
• Dependency On Imported Raw Materials
• Absence Of API Plant
• No Manufacturing Of Cancer & Hepatitis A,B or C Medicines
SWOT Analysis Of Beximco
Pharmaceuticals Limited(Cont.)
Opportunities
• More Specialized Products
• Increase In Exports
• Innovation
• Strategic Alliance
• Foreign Direct Investment(FDI)
Threats
• Local Competitors
• International Competitors
• DGDA Price Regulation
• Political Instability
CONCLUSION
 Being one of the most renowned and second largest pharmaceutical

companies in Bangladesh, Beximco Pharmaceuticals Limited enjoy
an overwhelming market share in exporting medicines throughout
more than 45 countries around the globe. Using their worldwide
recognition they should proceed on expanding their business by
exporting their products in other countires & they also have the
opportunity to concentrate on Foreign Direct Investement.
 One of the key elements of their success is the R&D team for which
they have been able to successfully launch new medicines in the
market.
 With the threat of new entrants and existing local & international
pharmaceutical companies, the business has become highly
competitive. Therefore, launching specialized medicines, specially
for cancer, hepatitis A,B,C , hormonal disorder , sarcoidosis and
other lethal diseases , can put them in a distinguished position
among the competitors .

BEXIMCO Bus 101

Uploaded by

Copyright:

Available Formats

BEXIMCO Bus 101

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

BEXIMCO Bus 101

Uploaded by

Copyright:

Available Formats

An In-Depth Analysis Of

Md.Salehin Shahriar…………………… ID- 1220711030

 Beximco Pharmaceuticals Ltd. ( Beximco Pharma) is a part of

 Beximco was founded in the 1970’s by two brothers – Ahmed Sohail

Vision : We will be one of the most

At any general meeting:

Arlin & Napa Decomit 50 HFA

Opton 40 & Proceptin 40 Xalamprost

Cesonide HFA 80 Syringe

 Being one of the most renowned and second largest pharmaceutical

You might also like